| 标题 |
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of clinical oncology : official journal of the American Society of Clinical Oncology 作者:Gradishar WJ; Krasnojon D; Cheporov S; Makhson AN; Manikhas GM; et al 出版日期:2009/08/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)